Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Taibao Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and production of external preparations and traditional Chinese medicines. Established in 1989 and headquartered in Wenzhou, the company is a leader in transdermal drug delivery systems, particularly known for its medicated patches and cataplasms. Its product portfolio primarily targets pain management, orthopedics, and rheumatology, featuring well-known brands like the Taibao series of anti-inflammatory patches. The company operates modern, GMP-certified manufacturing facilities and maintains a robust distribution network across mainland China. Taibao continues to innovate in the field of topical drug delivery to provide effective localized treatments with minimized systemic side effects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taibao.